Zrc Wealth Management, LLC Akero Therapeutics, Inc. Transaction History
Zrc Wealth Management, LLC
- $278 Billion
- Q3 2025
A detailed history of Zrc Wealth Management, LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Zrc Wealth Management, LLC holds 202 shares of AKRO stock, worth $10,847. This represents 0.0% of its overall portfolio holdings.
Number of Shares
202
Previous 202
-0.0%
Holding current value
$10,847
Previous $10.8 Million
11.02%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AKRO
# of Institutions
297Shares Held
92.2MCall Options Held
1.72MPut Options Held
901K-
Janus Henderson Group PLC London, X06.74MShares$362 Million0.19% of portfolio
-
General Atlantic LLC New York, NY5.73MShares$308 Million10.64% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$300 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.48MShares$294 Million4.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.53MShares$243 Million0.0% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.49B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...